Welcome to Boehringer Ingelheim

So that we can provide you with the most appropriate information on our medicines please confirm who you are:
Find side effects reporting information at the bottom of this page
If you are a UK Healthcare Professional, please visit our Healthcare Professional website here

Chronic obstructive pulmonary disease (COPD)

Chronic obstructive pulmonary disease (COPD)

What is COPD?

COPD is a group of long-term conditions caused by damage to the lungs, which can make it difficult to breathe.1,2

When patients have COPD, the air sacs inside their lungs may collapse when breathing in and the airways may become inflamed and narrowed.1,2

Symptoms

Patients with COPD may experience some of the following symptoms, which can make it harder to carry out everyday tasks:2

 
Increasing shortness of breath when active
Increasing shortness of breath when active
Frequent chest infections
Frequent chest infections
Persistent wheezing and a chesty cough
Persistent wheezing and a chesty cough

How is COPD treated?

Inhaled medicines are usually used to treat COPD to help patients manage their symptoms.2,3

What is STRIVERDI® Respimat®?

STRIVERDI® Respimat® contains a medicine called olodaterol. It belongs to a group of medicines called long-acting bronchodilators, which help to open the airways and make it easier to get air in and out of the lungs. STRIVERDI® Respimat® helps adult patients who have COPD to breathe more easily.3

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Some uncommon side effects (may affect up to 1 in 100 people) which may be experienced when taking STRIVERDI® Respimat® include symptoms of common cold, dizziness and rash.

Stop taking this medicine and tell your doctor straight away if you notice any of the following serious side effects – you may need urgent medical treatment:

  • Immediate allergic reactions such as rash, nettle rash (urticaria), swelling of the mouth and face or sudden difficulties in breathing (angioneurotic oedema)
  • Unexpected tightness of the chest, coughing or wheezing or breathlessness immediately after inhalation (bronchospasm).3

Please refer to the patient information leaflet for further information about possible side effects.

References
  1. Asthma + Lung UK. What is COPD? Available from: https://www.asthmaandlung.org.uk/conditions/copd-chronic-obstructive-pulmonary-disease/what-copd (Accessed August 2023).
  2. NHS. Chronic obstructive pulmonary disease (COPD). Available from: https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/ (Accessed August 2023).
  3. STRIVERDI® Respimat® Patient Information Leaflet.

Where can I find more information?

Patient Information Leaflet

The Patient Information Leaflet is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using this medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Summary of Product Characteristics

The Summary of Product Characteristics (SmPC) tells healthcare professionals, such as doctors, pharmacists and nurses, how to prescribe and use this medicine correctly. The information in the Patient Information Leaflet and Summary of Product Characteristics are not intended to replace the opinion of a healthcare professional.

NP-GB-103699August 2023

Side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in package leaflet.

You can also report side effects directly to the Yellow Card scheme of https://yellowcard.mhra.gov.uk/

By reporting side effects you can help provide more information on the safety of the medicine.

Woman sitting comfortably on a couch with her dog while reading from her iPad